NCT00096083 Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer Status COMPLETED Phase PHASE2
NCT00094562 A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss Status COMPLETED Phase PHASE2
NCT00091858 Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer Status COMPLETED Phase PHASE3
NCT00089141 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Status TERMINATED Phase PHASE3
NCT00086528 Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00083434 Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy Status TERMINATED Phase PHASE3
NCT00083213 Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00082823 Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00082433 Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Status COMPLETED Phase PHASE3
NCT00082368 PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy Status COMPLETED Phase PHASE2
NCT00079222 Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Status COMPLETED Phase NA
NCT00069277 Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00066404 Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Status COMPLETED Phase PHASE1
NCT00064883 Radiation Therapy and the Natural History of Childhood Cancers Status COMPLETED Phase N/A
NCT00064857 Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors Status COMPLETED Phase PHASE2